Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
805.9
INR
|
+0.59%
|
|
+1.47%
|
+3.79%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
51,299
|
36,226
|
16,376
|
25,321
|
65,840
|
42,972
|
Enterprise Value (EV)
1 |
52,856
|
35,991
|
18,002
|
26,231
|
68,576
|
43,965
|
P/E ratio
|
9.6
x
|
5.25
x
|
4.93
x
|
15.3
x
|
11.8
x
|
10.5
x
|
Yield
|
0.93%
|
1.62%
|
3.59%
|
2.32%
|
1.12%
|
4.02%
|
Capitalization / Revenue
|
2.09
x
|
1.15
x
|
0.6
x
|
1.04
x
|
1.75
x
|
0.95
x
|
EV / Revenue
|
2.16
x
|
1.14
x
|
0.66
x
|
1.08
x
|
1.82
x
|
0.97
x
|
EV / EBITDA
|
6.72
x
|
3.22
x
|
3.1
x
|
7.39
x
|
6.97
x
|
3.84
x
|
EV / FCF
|
93.9
x
|
19.7
x
|
-13.9
x
|
11.9
x
|
-40.6
x
|
3,557
x
|
FCF Yield
|
1.06%
|
5.07%
|
-7.21%
|
8.43%
|
-2.46%
|
0.03%
|
Price to Book
|
1.34
x
|
0.84
x
|
0.36
x
|
0.47
x
|
1.12
x
|
0.7
x
|
Nbr of stocks (in thousands)
|
73,437
|
73,437
|
73,437
|
73,437
|
73,437
|
73,437
|
Reference price
2 |
698.6
|
493.3
|
223.0
|
344.8
|
896.6
|
585.2
|
Announcement Date
|
8/3/18
|
8/31/19
|
8/25/20
|
8/26/21
|
8/4/22
|
9/1/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
24,521
|
31,614
|
27,246
|
24,295
|
37,587
|
45,165
|
EBITDA
1 |
7,867
|
11,180
|
5,807
|
3,549
|
9,833
|
11,454
|
EBIT
1 |
6,595
|
9,791
|
4,225
|
1,841
|
7,893
|
8,732
|
Operating Margin
|
26.89%
|
30.97%
|
15.51%
|
7.58%
|
21%
|
19.33%
|
Earnings before Tax (EBT)
1 |
7,494
|
10,163
|
4,909
|
2,347
|
8,264
|
6,951
|
Net income
1 |
5,345
|
6,902
|
3,321
|
1,657
|
5,598
|
4,096
|
Net margin
|
21.8%
|
21.83%
|
12.19%
|
6.82%
|
14.89%
|
9.07%
|
EPS
2 |
72.78
|
93.98
|
45.22
|
22.57
|
76.22
|
55.78
|
Free Cash Flow
1 |
562.7
|
1,824
|
-1,299
|
2,212
|
-1,688
|
12.36
|
FCF margin
|
2.29%
|
5.77%
|
-4.77%
|
9.11%
|
-4.49%
|
0.03%
|
FCF Conversion (EBITDA)
|
7.15%
|
16.32%
|
-
|
62.34%
|
-
|
0.11%
|
FCF Conversion (Net income)
|
10.53%
|
26.43%
|
-
|
133.48%
|
-
|
0.3%
|
Dividend per Share
2 |
6.500
|
8.000
|
8.000
|
8.000
|
10.00
|
23.55
|
Announcement Date
|
8/3/18
|
8/31/19
|
8/25/20
|
8/26/21
|
8/4/22
|
9/1/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,556
|
-
|
1,626
|
910
|
2,736
|
993
|
Net Cash position
1 |
-
|
236
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.1978
x
|
-
|
0.2799
x
|
0.2565
x
|
0.2783
x
|
0.0867
x
|
Free Cash Flow
1 |
563
|
1,824
|
-1,299
|
2,212
|
-1,688
|
12.4
|
ROE (net income / shareholders' equity)
|
14.9%
|
17%
|
7.47%
|
3.32%
|
9.93%
|
6.81%
|
ROA (Net income/ Total Assets)
|
8.76%
|
11.7%
|
4.62%
|
1.76%
|
6.52%
|
6.69%
|
Assets
1 |
60,986
|
59,219
|
71,823
|
93,939
|
85,851
|
61,218
|
Book Value Per Share
2 |
520.0
|
585.0
|
626.0
|
732.0
|
803.0
|
836.0
|
Cash Flow per Share
2 |
9.630
|
26.20
|
5.770
|
48.40
|
40.50
|
62.00
|
Capex
1 |
2,848
|
3,862
|
5,738
|
7,941
|
9,087
|
6,831
|
Capex / Sales
|
11.61%
|
12.22%
|
21.06%
|
32.68%
|
24.18%
|
15.12%
|
Announcement Date
|
8/3/18
|
8/31/19
|
8/25/20
|
8/26/21
|
8/4/22
|
9/1/23
|
|
1st Jan change
|
Capi.
|
---|
| +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +16.93% | 14.96B | | +7.73% | 15.03B |
Other Commodity Chemicals
|